谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary Table S6 from Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study

Yuqin Song,Zhengming Jin,Zhi-Ming Li,Yanyan Liu,Lanfang Li,Chuan He,Hang Su,Hui Zhou,Kunyan Li,Siguo Hao,Xuelan Zuo,Jianyuan Wu,Dengju Li,Meng Wu,Xiuhua Sun,Junyuan Qi,Zhen Cai,Zengjun Li,Yijing Li,Yanhua Huang,Jie Shen,Zhenyu Xiao,Jun Zhu

crossref（2024）

引用 0|浏览18
暂无评分
摘要
Supplementary Table S6. All serious adverse events.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要